Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 65,666 |
|
|||||
| News | - | ||||||
| Day High | 1.51 | Low High |
|||||
| Day Low | 1.40 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Compass Therapeutics Inc | CMPX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.08 | -5.41% | 1.40 | 23:00:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.51 | 1.40 | 1.51 | 1.45 | 1.48 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 423 | 65,666 | US$ 1.48 | US$ 97,019 | - | 1.15 - 3.62 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:30:09 | 1 | US$ 1.40 | USD |
Compass Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 184.86M | 127.49M | - | 0 | -42.49M | -0.33 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Compass Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CMPX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.47 | 1.59 | 1.33 | 1.48 | 205,373 | -0.07 | -4.76% |
| 1 Month | 1.98 | 1.98 | 1.33 | 1.63 | 370,405 | -0.58 | -29.29% |
| 3 Months | 1.23 | 2.34 | 1.15 | 1.77 | 383,738 | 0.17 | 13.82% |
| 6 Months | 1.79 | 2.34 | 1.15 | 1.69 | 450,698 | -0.39 | -21.79% |
| 1 Year | 2.61 | 3.62 | 1.15 | 2.24 | 429,693 | -1.21 | -46.36% |
| 3 Years | 4.10 | 5.65 | 1.15 | 2.66 | 313,498 | -2.70 | -65.85% |
| 5 Years | 4.10 | 5.65 | 1.15 | 2.66 | 313,498 | -2.70 | -65.85% |
Compass Therapeutics Description
| Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. The company has drugged over 40 immune targets and generated a diverse pipeline of monoclonal and multispecific therapeutic candidates with potential to transform care for patients with cancer or autoimmune diseases. |
